Benralizumab reduces blood basophil percentage and activation in vitro without eliciting degranulation

Allergy. 2024 Sep;79(9):2551-2553. doi: 10.1111/all.16190. Epub 2024 Jun 6.
No abstract available

Keywords: basophils; benralizumab; immunology; severe eosinophilic asthma; treatment.

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / pharmacology
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Basophils* / drug effects
  • Basophils* / immunology
  • Basophils* / metabolism
  • Cell Degranulation* / drug effects
  • Humans
  • Leukocyte Count

Substances

  • Antibodies, Monoclonal, Humanized
  • benralizumab